Researchers at GIGA have a large expertise in the analysis of thiamine compounds. Few years ago, they have discovered a new thiamine derivative: the adenosine thiamine triphosphate.

Their current research focuses on the use of thiamine and its precursors as therapeutic agents in neurodegenerative diseases due to their high bioavailability. More particularly, they aim at identifying the pharmacologically active thiamine compound and investigating its mechanisms of action.

Interested in these projects? Drop us an email []. We are looking forward collaborating with you!